Their ongoing negotiations remain shrouded in secrecy, but there are already reports that India and the European Union (EU) will have a free-trade agreement ready by the end of August, and that they will be putting signatures to it before the end of 2010. Yet it is a potential development that is causing more nervous chatter than joyous jitters here in India, where drug manufacturers in particular have raised concerns over...
More »SEARCH RESULT
Total Matching Records found : 171
Medicines bought in bulk by govt can help cut costs by Subodh Varma
By spending just Rs 6,000 crore, the government can make a huge dent in the treatment of all sick people across the whole country — currently, people are spending as much as Rs 25,000 crore on buying essential medicines. This was the strong message sent out from a National Consultation organized by several civil society groups at New Delhi on Tuesday. Officials of the health ministry and the Planning Commission...
More »Keeping The Poor Alive by Dipankar Gupta
Poverty attracts two kinds of policy interventions. The first hopes to eradicate it and the second wants to keep the poor alive. In India, our prime effort has always been, right from the days of antodaya, to somehow keep the poor ticking, even at the lowest levels of subsistence. The NREGA scheme saves the impoverished from starvation on a six-monthly basis. We see the same mindset at work in the...
More »A bad example from the US by Leena Menghaney
India has played a crucial role in making essential medicines available and affordable for patients in the developing world through generic drugs. This has been possible by linking India’s patent policies and laws to public interest. Similarly, policies that align public funded R&D in India with public health have the potential to provide incentives to the development of medical technologies (vaccines, diagnostics and medicines) crucial for treating neglected diseases like...
More »Public Health
KEY TRENDS • The 2019 India TB report says that the country accounted for a quarter of the global tuberculosis (TB) burden with an estimated 27 lakh cases in 2018. In 2018, the country was able to achieve a total notification of 21.5 lakh TB cases, of which 25 percent was from private sector. Majority of the TB burden is among the working age group. Nearly 89 percent of TB cases came from the age group 15-69 years....
More »
